abstract |
Disclosed is a pharmaceutical composition for use in the treatment or prevention of diseases or conditions associated with nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), such as cardiovascular disorders. A pharmaceutical composition containing a pyrazolopyridine derivative represented by the following formula: [Selection figure] None |